Related by context. All words. (Click for frequent words.) 78 xxii 74 xvii 72 xviii 71 xix 71 xiv 70 xiii 70 viii 69 xvi 68 xii 67 xxiii 65 xv 65 ix 65 vii 64 xxiv 63 xxvi 62 xxxii 61 xxvii 61 xxviii 61 xxv 61 xi 60 Immtech clinical trials 60 iv 59 requirements xxii 58 iii 56 legal proceedings xxi 55 materially adversely affect 55 multiple lease terminations 54 vi 54 Immtech scientists 53 xxxiii 53 ii 53 adversely affect 52 SeraCare competitors 52 timing rescheduling 52 affecting mortality morbidity 52 risksassociated 52 Unitholder liability 51 adverse determinations 51 consummating acquisitions 51 impactof 50 regarding Heska 50 changesin 50 collect reinsurance recoverables 50 nonoccurrence 50 risks associatedwith 50 withrespect 50 ability tosuccessfully 50 substantial indebtedness 50 Pure Biofuels ability 49 contingent guaranties 49 general economicconditions 49 ourability 49 statementsregarding 49 consolidations restructurings bankruptcies 49 Projects Initiation 49 i# implanters 49 tenant bankruptcies 49 affirmative covenants 49 unanticipated 49 successfully integrate 49 unanticipated difficulties 49 PharMerica LTC Transaction 49 REIT xi 49 indebtedness covenant 48 retrocessional coverage 48 affecting Pennichuck Corporation 48 unitholder liability 48 Prelude SkinPrep Systems 48 expropriation nationalization 48 incurrence 47 notlimited 47 adversely affect Univest Corporation 47 market PolyHeme commercially 47 delinquencies defaults 47 without limitation 47 tarmac strandings Hanni 47 unanticipated geological 47 work stoppages quarantines 47 risks anduncertainties 47 otherfactors 47 deploy MDCE services 47 ceded reinsurance 47 permitting timelines 47 HANA MAX 47 Market Disruption 47 thereby negatively impacting 47 vii IBC 47 relating 47 governmental approvals 47 DSL.net s 47 economicconditions 47 relatedto 46 affecting Amarin 46 Excluding acquisitions divestitures 46 acquisitions dispositions 46 limitedto 46 ultimate recoverability 46 differ materiallyfrom 46 impacting WesBanco 46 market fluctuations investee 46 Crisa acquisition 46 orotherwise 46 prepayment speeds loan originations 46 anduncertainties 46 xxix 46 PLAVIX R patent 46 party VLSI fabrication 46 d Reflects 46 commercialize ZYFLO CR 46 Black Canyon mica 46 adversely affect FNB 46 xiv licensing 46 causeactual results 46 inventory obsolescence 46 withoutlimitation 46 adversely affect Waste Connections 46 BioSante licensees 46 contingently liable 46 work stoppages slowdowns 45 otherrisks 45 PLIVA acquisition 45 EPIXTAR 'S 45 retail industries repositionings 45 uncertainties materialize Shire 45 technological obsolescence 45 liabilities slippage 45 af fected 45 arenot limited 45 dispositions financings 45 negatively impact 45 ADSI reliance 45 ourproducts 45 resultof 45 unfavorable geologic 45 especially Copaxone ® 45 affect Petroflow 45 pandemics impacting 45 vi vii 45 uncertainties materialize Shire plc 45 refinance indebtedness 45 d Represents 45 capture exosomes 45 risks associated 45 Protonix ® 45 hyperinflationary environments 45 couldcause actual results 45 incur unanticipated 45 SANCTURA SANCTURA XR NEBIDO 45 SUPPRELIN LA DELATESTRYL 45 adversely affected 45 Phyto Source LP 45 technological innovations adversely affecting 45 MGCD# MGCD# [002] 44 without limitation Terremark 44 FierceGovernmentIT tracks 44 lender consents 44 MTI MTI Micro 44 SANCTURA SANCTURA XR VANTAS 44 Thalomid R 44 securityholder approvals 44 Cautionary Disclosures 44 related thereto 44 f h 44 couldcause 44 areforward looking 44 Johnell O 44 involverisks 44 CCR5 inhibitors entry 44 renegotiation nullification 44 EMPOWER pivotal trial 44 cancellations rescheduling 44 associatedwith 44 collectibility 44 xv licensing 44 de novo branching 44 associated therewith 44 reinsurance recoverables owed 44 [013] 44 orother 44 Risks uncertainties 44 xxvi introduction 44 SURETY LICENSES c 44 MGCD# MGCD# [001] 44 mergers consolidations 44 Auxilium anticipates 44 HF Lenfest member 44 gastrointestinal GVHD include 44 product discontinuances 44 § #.#-# [004] 44 obtaining regulatory approvals 44 persistency mortality 44 Heska reliance 44 borrower depositor 44 xv adverse 43 affecting O2Micro 43 intercompany arrangements 43 risks unanticipated reclamation 43 expenses associated therewith 43 andgeneral 43 b Relates 43 adversely affect NextEra Energy 43 embolic coiling 43 adverse 43 adversely affecting 43 Item IA 43 vii viii 43 prices drydocking 43 adversely impact 43 retrocessional reinsurance 43 Yima project 43 representations warranties covenants 43 including withoutlimitation 43 JLG acquisition 43 VYVANSE TM lisdexamfetamine 43 Textainer expectation 43 Sepracor anticipates 43 FIDAC regulatory 43 Mago ® 43 OraTest R 43 vii Dynamic 43 optimization seasonality 43 c Relates 43 obsolete inventory 43 BiDil XR drug 43 Filtran Microcircuits Inc. 43 Telesat Telesat leverage 43 Bioaccelerate compounds under 43 current physiologic opioid 43 postretirement benefit obligations 43 CompAir acquisition 43 TranSwitch indebtedness 43 CAUTION ANY ATTEMPT 43 mergers dispositions 43 suchforward looking 43 fluctuations cyclicality 43 results ofoperations 43 manufacture PolyHeme 43 c Reflects 43 refund guarantors 43 microcirculatory improvement 43 Secure Computing periodic 43 differ materially fromthose 43 concerning AudioCodes 43 impair FPL 43 Nortel strategic alliances 43 Erythropoietic therapies may 43 HYVISC R 43 events thrombocytopenia neutropenia 42 h r 42 Silver Wheaton purchases 42 LAE reserves 42 diminishing quantities 42 Merger Transactions 42 uncollectible accounts receivable 42 others Mannatech inability 42 maydiffer materially 42 Gastroesophageal Reflux 42 marketconditions 42 Colihues tailings impoundment 42 SumTotal Systems filings 42 aresubject 42 Rexahn licensees 42 satisfy indemnification obligations 42 depreciation accretion 42 Candente relies upon 42 risksand uncertainties 42 Detrex stock 42 accounting pronouncements 42 differmaterially 42 non capitalizable 42 omission interruption deletion defect 42 VIOXX Lawsuits 42 brine inflows 42 factors thatcould 42 uncertainties materializes FICO 42 website www.FreePennyAlerts.com 42 site www.buyins.net 42 periodic redeterminations 42 outbreaks epidemics 42 disinterested Shareholder approval 42 ENABLE Phase 2 42 VimpelCom disclaims 42 depreciation depletion amortization 42 Inventory write downs 42 P. #a 42 xviii currency 42 Shire plc Attention Deficit 42 involve risksand uncertainties 42 filingswith 42 difficulties foreseeing 42 - -Billeaudeau 42 g Represents 42 materially adversely affected 42 Accurel 42 communicate differentiations effectively 42 Web site http:/www.EmergingStockReport.com 42 OREO valuation 42 Congoleum undertakes 42 Bioenvision compounds under 42 c html plugins 42 fluctuations 42 u t 42 i g 42 VELCADE therapy 42 intercompany indebtedness 42 theforward looking 42 minerals inc 42 FastFunds Financial Corporation 42 xxxi 42 expressed orimplied 42 franchisees licensees 42 Unanticipated 41 proprietary Capillary Aerosolization Technology 41 affect Zygo Corporation 41 #.#-# b [002] 41 #.# subd [003] 41 SANCTURA R 41 Therics LLC 41 goals expectations anticipations 41 affect NYMET Holdings 41 website www.gladiatorstocks.com 41 joint ventures strategic alliances 41 viii insufficient 41 b Represents 41 governmental payors 41 materially impair 41 integrate CyVera technology 41 economically recoverable coal 41 Disruptions uncertainty 41 successfully integrate Legerity 41 positive inotropic agents 41 iii iv 41 may diverge numerically 41 examinations vaccinations spaying 41 operated bakery cafe 41 event reporting Clintrace 41 incorporate proprietary Microvolt 41 xvi beer 41 website www.PennyStockAlley.com 41 Relates 41 n h r 41 y u 41 BY AN ENTRANT 41 torsemide ER 41 prescription brands RESTYLANE 41 REMOVAL Removal shall 41 natural disasters epidemics 41 Partially offset 41 inflationary pressures adversely affecting 41 React NTI 41 Omtool periodic reports 41 Insolvency Proceedings 41 product introductions 41 AXXX 41 DISMISSED WITH PREJUDICE 41 FalconStor OEM 41 BOPET film industry 41 costs associated therewith 41 theCompany 41 Becancour facilities 41 § #.#-# [007] 41 contemplated hereunder 41 workersa compensation 41 maycause actual results 41 h g 41 dd DISCOUNTS R 41 reasonably determinable 41 adversely affect Linktone 41 TeamStaff GS 41 Knoxville MSA 41 cranes Fuchs 41 asset impairments 41 Idenix anticipates 41 TRISENOX R 41 redomestication 41 Zi OEM 41 unambiguously preclude 41 adversely affecting Cubist 41 R DYNACIN R 41 § #-#-# [005] 41 candidate Ramoplanin 41 Nortel unfunded 41 ARLP Partnership 41 forwarda ^ looking 41 Cerro Negro concession 41 ofany 41 xiv unanticipated 41 adversely affect Hologic 41 y h 41 r l 41 assimilating acquired 41 CORLUX CORT # 41 Daytrana TM 41 TP# CETi 1 41 c Represents 41 vendor unseasonable weather 41 Publication Classified Ad 41 credit carryforwards 41 Reinsurance recoverables 41 differ materially 41 Fampridine SR delays 41 n h 41 actualresults 41 Tekmira disclaims any 41 minesites 41 thepotential 41 PGP Acquisition 41 website StockPreacher.com 41 PolyHeme successfully 40 RR Donnelley periodic filings 40 JEVCO 40 risks associated therewith 40 distinguishing MDCE products 40 h y 40 Invitel Holdings operates 40 Including newbuildings 40 c Excludes 40 Oxandrin R 40 AcryMed Incorporated 40 Colo. Sess 40 Somewhat mitigating 40 Company noncontributory defined 40 repopulate neural liver 40 Activision Publishing maintains 40 Partially offsetting these 40 Iusacell Celular 40 xxiii numerous 40 manufacture RISPERDAL CONSTA 40 Accrual 40 surety bonding increased 40 CAUTIONARY STATEMENT Statements 40 andbusiness 40 EHSK 40 Liftking 40 t r 40 affecting IsoTis 40 NitroMed BiDil 40 strategic alliances seasonality 40 Exelbine 40 #.#-# b [001] 40 AcryMed technologies 40 Nortel Networks strategic alliances 40 regulatory authorizations 40 andoperating 40 requisite stockholder 40 competing steel minimills 40 website GreenGainers 40 CholeraGarde R Peru 40 acquisitions divestitures 40 party payors 40 className nodes nodes.length = 40 maycause 40 thereunder 40 Equinix filings 40 negatively affect 40 TECSYS Inc. 40 AspenTech periodic reports 40 cadence regulatory approvals 40 competitively procured pursuant 40 Income Tax Regs 40 regulatory approvals 40 VeraTag assays 40 Bo Scaife TE 40 STRIANT ® 40 Infor expressly disclaims 40 PD2i Analyzer 40 PXRE undertakes 40 impair Lillian Vernon 40 reinsurance ceded 40 Bioenvision filings 40 e h r 40 ISX Data.com uses SafeDinar 40 products visit www.adm.com 40 dispositions 40 merchant chargebacks 40 affecting OmniComm 40 follows Obagi Nu 40 BioFX Laboratories 40 prepayment speeds loan 40 currency fluctuations imprecision 40 § #-#-# b [003] 40 intellectual property litigations 40 adversely affect FPL 40 CLX Investments 40 Partnered Brands segment 40 Westell accounting 40 anyforward looking 40 reflect VIQ Solutions 40 xxii imposition 40 Innodata Isogen acquires 40 uncertainties 40 theability 40 uncertaintiesthat 40 SearchHelp communications 40 Multiemployer Pension Plan 40 str = i 40 o l 40 statements arebased 40 Kinsevere copper mine 40 Chase Kishner 40 Bioenvision dependence 40 successfully commercialize REOLYSIN 40 STRIANT R 40 unless Widrlechner 40 Varvarinskoye Project 40 reestimates 40 Shire Attention Deficit 40 serious cardiovascular thrombotic 40 VIOXX Product 40 mortality morbidity 40 involve risks anduncertainties 40 ® Protonix 40 - -champioship 40 NxStage anticipates 40 Biogold Fuels 40 affect theglobe.com 40 uncollectible accounts expense 40 integrating Aleris 40 Lenfest ii 40 Section #e 40 FuelQuest solutions 40 inaccuracy therein 40 materially affect 40 wholly owned subsidiary IPCRe 40 sites xix limitations 40 materially differ 40 EcaFlo TM 40 andfinancial 40 e mail lifestyle@readingeagle.com 40 5 lipoxygenase inhibitor 40 xi unanticipated 40 futureresults 40 promulgated thereunder 40 collectability 40 damage cirrhosis liver 40 detrimentally affected 40 LOPROX R 40 Form #KSB filed 40 DELETE OR EDIT COMMENTS 40 un placement privé 40 redundancy scalability 40 EcaFlo ® equipment 40 ofnew 39 todiffer materially 39 postretirement benefit plans 39 Copano commodity 39 includingstatements regarding 39 #.#-# Equal Opportunity 39 dimesylate Attention Deficit 39 hurricanes earthquakes 39 Proteus Adonis Meridius IPAM 39 GEROVA underwrites insurance 39 love veronica Mars 39 SumTotal Enterprise 39 OSI Pharmaceuticals filings 39 bleeding ulceration 39 acquisitions divestitures restructurings 39 FAFLIC 39 Prospective Bidder may 39 Zemiva ™ 39 Mid Continent Permian Basin 39 objectives therefor 39 Somaxon ability 39 Pixelplus cautions readers 39 constitutes discloseable transaction 39 cyclicality fluctuations 39 attendant thereto 39 CV thrombotic 39 rapid technological 39 date xvii Conversion 39 YASH Technologies focuses 39 productsand services 39 adversely effecting 39 Questcor intellectual property 39 ii Immtech ability 39 vQsQn 39 treat cerebral aneurysms 39 visit www.ethosfr.com 39 affect GSI Commerce 39 enforce MOSAID 39 adversely impacts 39 i #.# subds 39 Nortek Holdings 39 Metalline anticipated 39 retain drilling rigs 39 b Excludes 39 OneBeacon filings 39 Monovisc 39 proximately caused 39 AGGRASTAT R tirofiban hydrochloride 39 Somewhat offsetting these 39 AngelCiti expectations 39 heading ITEM 1A 39 Armtec Limited Partnership 39 incorporate CXA 39 embargoes natural disasters 39 Miraculins cautions 39 CompanyaEUR TM s 39 Reported Unaudited Condensed 39 should consult NeurogesX 39 counterparty creditworthiness 39 Aspyra actual 39 mmoore@equicomgroup.com 39 Inefficiencies arise 39 reflect Ronn Motor 39 #.#A [005] 39 distribution metabolism excretion 39 Fabrinet focuses 39 GenVec filings 39 COPL 39 DTR #.#.# b 39 r t 39 PD2i Cardiac Analyzer 39 - -Commey 39 Form 8K #K 39 IEVM 39 o h 39 xxxv 39 necessary regulatory approvals 39 please visit www.advantex.com 39 OPAXIO pixantrone 39 arising 39 TrueKnowledge Platform TM 39 Repl. 39 refl ects 39 Slightly offsetting 39 theseforward looking 39 Ambrilia views 39 l w 39 Voxware evolving distribution 39 y r 39 Priszm LP 39 VanceInfo filings 39 qW 39 i# implanter 39 u h 39 affecting BEO Bancorp 39 carbonate Direct FuelCell 39 Avivo Corporation 39 cause actualresults 39 principally attributable 39 involve anumber 39 commercializing ArteFill 39 manganese ii 39 SciClone filings 39 Zindart 39 pricing pressures 39 geographic concentration 39 GELV gasification technology 39 Asset impairment 39 Denville Scientific 39 vii Cubist ability 39 Exelixis compounds 39 forward.looking statements 39 CFR #.#b 39 xx 39 RISKS AND UNCERTAINTIES 39 worsening peripheral neuropathy 39 didanosine associated 39 unforeseen underperformance 39 unfavorably impacted 39 eptifibatide Injection 39 CSLR expectations 39 DIP Loan 39 affecting 39 sublease recoveries 39 andeconomic 39 reject unexpired 39 arebased 39 contingent liabilities 39 currency fluctuations 39 purchaserâ € ™ 39 paul dev da 39 InnSuites Hotels 39 strategic reallocations 39 Oxandrin ® 39 h u 39 affect Pennichuck Corporation 39 Airvana anticipates 39 w # yQ 39 intents beliefs 39 assorted pigments resins 39 infringed misappropriated invalid 39 XL# anticancer compounds 39 alemtuzumab MS 39 Tucows filings 39 PAIVIS actual 39 d h 39 AzaSite Xtra 39 g o 39 commercialize BiDil 39 unforeseen occurrences 39 Operations contained therein 39 ourbusiness 39 assumptions underlying 39 dispositions joint ventures 39 Montanore Project 39 #.# subd [004] 39 ii iii 39 NeuCo changes 39 customers licensees licensors 39 postretirement benefit 39 ExchangeCommission 39 FGIC insured 39 hepatic dysfunction 39 Shigamabs 39 Kronos TiO2 39 x fluctuating beryllium 39 inattention drowsiness 39 Safeguard participates 39 favorably impacted 39 Partially offsetting 39 anticipated drydocking 39 requisite regulatory approvals 39 forward lookingstatements 39 Esterhazy Saskatchewan potash 39 Orrstown Financial conducts 39 KNA ULC 39 vi renegotiation nullification 39 EDGAR Online via COMTEX 39 Tronox Annual Report 39 joint ventures divestitures 38 directionally consistent 38 InfoSearch filings 38 Largely offsetting 38 INTEGRILIN R eptifibatide Injection 38 risks uncertainties 38 NNL failure 38 Kyowa Kirin 38 negatively impacted 38 Note Copper Equivalent 38 Azixa ™ 38 Direct Indirect x 38 KRYSTEXXA TM 38 Alnylam dependence 38 nonhematologic adverse reactions 38 relative illiquidity 38 RETURN POLICY If 38 Theseforward looking 38 f o 38 geological metallurgical 38 des paiements 38 early extinguishments 38 tiny pteropod 38 brentuximab vedotin pivotal 38 OCC OTS Federal Reserve 38 mutually satisfactory definitive 38 acquisitions mergers dispositions 38 HS Orka geothermal 38 partner lorcaserin APD# 38 reinsurance recoverables 38 PMACIC 38 1 HER1 pathway 38 Dynegy cautions 38 Panlab 38 successfully commercialize 38 adversely impacted 38 applicable dayrates 38 Polo Jeans Company 38 Defendants misrepresented 38 suchstatements 38 towering thunderheads lightning 38 impacted adversely 38 While Ambrilia anticipates 38 incorporating FalconStor 38 Julius Peppers DE 38 Acquisition constitutes discloseable 38 relate thereto 38 Statement Statements 38 CHDT SEC Filings 38 p r 38 Clairvest realizes value 38 -Duncalfe 38 APPY believes 38 collaborations Pharmacopeia 38 geology continuity 38 Symphony tCGM 38 strategic pharmacovigilance WebVDME 38 de ses 38 integrate restructurings consolidations 38 Cleco Midstream 38 c Consists 38 Gramercy Realty Lenders 38 Unfavourable 38 e# periodic 38 technology crystalline ingot 38 xxiv adverse effects 38 Kanis JA 38 incentive accruals 38 dd DISCOUNTS ® 38 Treatment discontinuations due 38 TeamStaff filings 38 Derm ® 38 morbidity mortality 38 Enhance Biotech 38 XP# XP# 38 @ y qW 38 website StockMarketLife.com 38 ofsuch 38 Midwest Consent Decree 38 Ethylene Oxide Ethylene Glycol 38 coûts 38 SG &A; 38 #.# subd [006] 38 unscheduled outages 38 shipper ie 38 uncollectable receivables 38 LOUIS Oshiomogho Atogwe 38 COFI regardless 38 polyvinyl chloride PVC chlor 38 Epigenetics refers 38 § #.# [004] 38 xii trademark 38 Ultitek faces 38 debt extinguishments 38 punitive incidental 38 related Functional Somatic 38 § #-#-# b [001] 38 NeoPharm anticipates 38 PepsiCo bottling 38 negatively impacts 38 amendments thereto 38 HealthGate ability 38 acquisitions divestitures mergers 38 RXi Pharmaceutical Corporation 38 Zemiva TM Trofex TM 38 Comarco Announces 38 Increases Bought Deal 38 www.ENGlobal.com 38 men bisexuals transgender 38 Farberware ® KitchenAid 38 Liability Lawsuits 38 iv unanticipated 38 following websites http:/www.nexmed.com 38 sequencing gene expression 38 reinsurance cessions 38 transactions contemplated 38 xxiii fluctuations 38 Completes Previously Announced 38 Varian Semiconductor dependence 38 subjectto 38 entities VIE 38 Orosi Mill project 38 # wQ 38 f Reflects 38 punctal plug 38 Acticoat TM products 38 XGen Nevis Island 38 asset monetizations 38 Offerors Commercial applies 38 Hemispherx involve 38 include sutures needles 38 TRUSTCASH 38 angina congestive heart 38 currency inconvertibility 38 BlackPearl Announces 38 visit http:/www.cytrx.com 38 MST reply 38 § #a [002] 38 commercialized Analyte Specific Reagents 38 customary representations warranties 38 Puricase PEG uricase 38 thereto 38 commercially mineable 38 nancial 38 reinsurance recoverable 38 materially overstated 38 Kindred Brookdale 38 materially overstating 38 Ferlay J et al 38 Goodwill impairment charge 38 http:/www.iridex.com 38 Rexahn actual 38 MultiCell bases 38 -lipid nanoparticles 38 hereinafter collectively 38 -DEAD BODY 38 hpSCs avoid ethical 38 de la société 38 concerning Epigenomics AG 38 uncollectability 38 novel therapeutic modality 38 Kayoko Kano acknowledged 38 adverse publicity 38 currentexpectations 38 ` vQsQn 38 l o 38 Refinancing Transactions 38 reorganizations mergers 38 provocation incitement 38 Magicalia assumes 38 Sunesis nonclinical studies 38 concerning Alexza 38 See USSG § #B#.# 38 Compans 38 - - [092] 38 strategic pharmacovigilance Empirica 38 offerings visit www.balqon.com 38 newbuilding deliveries 38 party semiconductor foundries 38 Discontinuations due 38 OR LOSS 38 subvented interest 38 distinguishing GigaBeam products 38 disable virulence 38 unfavorable prognostic 38 CSLR expectations regarding 38 definable pathways 38 uBid.com Holdings Inc. 38 ` rk 38 visit http:/www.nationwide.com 38 neutropenia thrombocytopenia 38 looking statementsare 38 Lexiscan R 38 Durus Life 38 NetVault TM 38 unfavorable variances 38 DFAR #.#-# 38 inflammatory autoimmune diseases 38 DJO Merger 38 supplemental indenture effecting 38 bone marrow fibrosis 38 TSX Venture AHR 38 theavailability 38 Och Ziff Operating 38 Fampridine SR Acorda Therapeutics 38 concerning Wowjoint 38 GRADE Closed 38 Agreement constitutes discloseable 38 Amyris oversees 38 stockholder approvals 38 CyberDefender expectation 38 ™ pralatrexate injection 38 andrelated 38 satellite datacasting market 38 relapsed acute myelogenous 38 Fusarium infection 38 Lithonia Lighting R 38 WNS ADS 38 update anyforward looking 38 Waratah Coal filings 38 Legerity acquisition 38 USC § #f 37 Risks Related 37 Nortel restatements 37 A.M. Best Assigns Ratings 37 molecular immunohematology 37 acquisitions divestitures strategic alliances 37 e mail Heloise@Heloise.com 37 Achillion anticipates 37 Seabridge cautions 37 histrelin manufacturing marketing 37 Second Supplemental Indenture 37 cicletanine 37 andour 37 Laurion cautions against 37 Effective Date #.# 37 Verlan Fire 37 opioid tolerance 37 fighter jets del Rosario 37 attribution authenticity provenance 37 newinformation future 37 ore densities 37 professionals technological obsolescence 37 g r 37 shipyards charterers lenders 37 vary materially 37 SonoPrep device 37 ProPhotonix 37 wagering ceasing 37 divestures 37 SuperStitch ® 37 GearUpForSports makes 37 EVIZON TM squalamine lactate 37 regarding allosteric modulators 37 successfully commercialize Iluvien 37 mGluR2 mGluR4 mGluR5 mGluR7 37 UTEK dependence 37 Restructuring impairment 37 INTEGRILIN ® 37 viii inability 37 XVIII disruption 37 #,#,# Commitments 37 c SIGA 37 Company 37 XLFA 37 concerning VAALCO 37 -hooker Marius Tincu 37 opioid agonists 37 idles factories 37 realizability 37 corporate reorganizations 37 CCAA Proceedings 37 inaccurate transmittal 37 LocatePLUS Statements 37 theimpact 37 o t 37 www.marlerblog.com 37 carryforwards